Table 2. Relationship of jSLE demographics and disease features to HRQOL and to presence of obesity^Ŧ.

Outcomes¶	HRQOL		Presenceof obesity
Predictors	Beta-coefficient or slope	P-value*	Odds ratio	P-value**
Age (< 12 years)	0.1	NS	0.6	NS
Gender: Female	0.2	NS	0.8	NS
Ethnicity: Hispanic	1.5	NS	1.3	NS
Race: African American	-8.8	0.01	2.3	0.01
At least moderate disease activity (Total SLEDAI score > 4)	-5.5	0.02	1.4	NS
More than minimal disease damage (Total SLICC score > 0)	-2.5	NS	0.6	NS
Current low daily prednisone dose (< 0.2 mg/kg/day and < 5 mg/day)	5.4	0.03	0.4	NS
Current immunosuppressive use	0.2	NS	1.2	NS
Current use of intravenous methylprednisolone pulses	1.7	NS	0.6	NS

Legend:

^ŦFor PedsQL Generic Core Scale. Results similar to summary scores of PedsQL-Rheumatology Module and CHQ. For the PedsQL-Rheumatology Module (self- report), gender is also significant

^¶Outcomes of univariate analyses are: A) summary scores of HRQOL measures (shown here: PedsQL-Generic Core Scale parent-report) and B) presence of obesity

^*P-value from univariate mixed effects analyses to evaluate association of covariate of interest to outcome (i.e. domains scores of HRQOL measures)

^**P-value from logistic regression to evaluate association of covariate to presence of obesity